Floatz logo

Flurbiprofen Axetil

Atrial Fibrillation (AF)

Beijing Anzhen HospitalN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

20 Active assets in the Atrial Fibrillation (AF) cohort.

Asset / SponsorPhaseRating
Edoxaban
National Taiwan University Hospital
Phase 4A
Rivaroxaban
VA Office of Research and Development
Phase 4BBB
Dabigatran
Pfizer
Phase 4BBB
Apixaban
Regeneron Pharmaceuticals
Phase 4BBB
WARFARIN
Pfizer
Phase 4BBB

View all 40 →

Same molecule, other indications

Flurbiprofen Axetil is also rated in:

Enhanced Recovery After SurgeryDormant
B
Indicative ·
56 / 100
View asset →
Multimodal AnalgesiaDormant
B
Indicative ·
56 / 100
View asset →
DexamethasoneDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →